PriCoTTF: A phase I/II single-arm trial of tumor treating fields prior and concomitant with radiotherapy and temozolomide in newly diagnosed glioblastoma

被引：0
|
作者：
Glas, M. [1 ]
Scheffler, B. [2 ]
Lazaridis, L. [1 ]
Herrlinger, U. [3 ]
Pierscianek, D. [4 ]
El Hindy, N. [4 ]
Sure, U. [4 ]
Proescholdt, M. [5 ]
Hau, P. [6 ]
Hense, J. [7 ]
Kleinschnitz, C. [8 ]
Combs, S. E. [9 ]
Grosu, A. -L. [10 ]
Stuschke, M. [11 ]
Kebir, S. [1 ]
机构：
[1] Univ Klinikum Essen, Klin Neuroonkol, Essen, Germany
[2] Univ Klinikum Essen, Translat Onkol, Westdeutsch Tumorzentrum, Essen, Germany
[3] Univ Klinikum Bonn, Klin Neuroonkol, Bonn, Germany
[4] Univ Klinikum Essen, Klin Neurochirurg, Essen, Germany
[5] Univ Klinikum Regensburg, Neurochirurg, Regensburg, Germany
[6] Univ Klinikum Regensburg, Neurol NeuroOnkol, Regensburg, Germany
[7] Univ Klinikum Essen, Innere Klin Tumorforsch, Essen, Germany
[8] Univ Klinikum Essen, Neurol Klin, Essen, Germany
[9] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin RadioOnkol & Strahlentherapie, Munich, Germany
[10] Univ Klinikum Freiburg, Klin Strahlenheilkunde, Freiburg, Germany
[11] Univ Klinikum Essen, Klin Strahlenheilkunde, Essen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2018年 / 194卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P02-5
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
  • [41] Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
    Compter, Inge
    Eekers, Danielle B. P.
    Hoeben, Ann
    Rouschop, Kasper M. A.
    Reymen, Bart
    Ackermans, Linda
    Beckervordersantforth, Jan
    Bauer, Noel J. C.
    Anten, Monique M.
    Wesseling, Pieter
    Postma, Alida A.
    De Ruysscher, Dirk
    Lambin, Philippe
    AUTOPHAGY, 2021, 17 (09) : 2604 - 2612
  • [42] TUMOR TREATING FIELDS COMBINED WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA: FINAL SAFETY AND EFFICACY RESULTS FROM A PILOT STUDY
    Grossman, R.
    Bokstein, F.
    Blumenthal, D.
    Ben Harush, C.
    Limon, D.
    Ram, Z.
    NEURO-ONCOLOGY, 2019, 21 : 84 - 84
  • [43] A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
    Werlenius, Katja
    Stragliotto, Giuseppe
    Strandeus, Michael
    Blomstrand, Malin
    Caren, Helena
    Jakola, Asgeir S.
    Rydenhag, Bertil
    Dyregaard, Dorte
    Dzhandzhugazyan, Karine N.
    Kirkin, Alexei F.
    Raida, Martin K.
    Smits, Anja
    Kinhult, Sara
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [44] Glasdegib in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II GEINO 1602 trial
    Vaz, M. A.
    del Barco, S.
    Sepulveda, J. M.
    Alonso, M.
    Pineda, E.
    Balana, C.
    Martinez-Garcia, M.
    Girones, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S393 - S393
  • [45] Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
    Omuro, Antonio
    Beal, Kathryn
    Gutin, Philip
    Karimi, Sasan
    Correa, Denise D.
    Kaley, Thomas J.
    DeAngelis, Lisa M.
    Chan, Timothy A.
    Gavrilovic, Igor T.
    Nolan, Craig
    Hormigo, Adilia
    Lassman, Andrew B.
    Mellinghoff, Ingo
    Grommes, Christian
    Reiner, Anne S.
    Panageas, Katherine S.
    Baser, Raymond E.
    Tabar, Viviane
    Pentsova, Elena
    Sanchez, Juan
    Barradas-Panchal, Renata
    Zhang, Jianan
    Faivre, Geraldine
    Brennan, Cameron W.
    Abrey, Lauren E.
    Huse, Jason T.
    CLINICAL CANCER RESEARCH, 2014, 20 (19) : 5023 - 5031
  • [46] Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experience
    Jalali, R.
    Basu, A.
    Gupta, T.
    Munshi, A.
    Menon, H.
    Sarin, R.
    Goel, A.
    BRITISH JOURNAL OF NEUROSURGERY, 2007, 21 (06) : 583 - 587
  • [47] A PHASE I TRIAL OF AFATINIB AND RADIOTHERAPY (RT) WITH OR WITHOUT TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    James, Allan
    McBain, Catherine
    Jefferies, Sarah
    Harris, Fiona
    Cseh, Agnieszka
    Pemberton, Karine
    Schaible, Jennifer
    Bender, Shaun
    Brada, Michael
    NEURO-ONCOLOGY, 2018, 20 : 20 - 20
  • [48] Randomized Phase II trial of Tumor Treating Fields plus radiation therapy plus temozolamide compared to radiation therapy plus temozolomide in patients with newly diagnosed glioblastoma
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Ben Harosh, Carmit
    Ram, Zvi
    CANCER RESEARCH, 2019, 79 (13)
  • [49] EF-32 (TRIDENT): A pivotal randomized trial of radiation therapy concomitant with temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma.
    Shi, Wenyin
    Kleinberg, Lawrence
    Jeyapalan, Suriya A.
    Goldlust, Samuel A.
    Nagpal, Seema
    Combs, Stephanie E.
    Roberge, David
    Nishigawa, Ryo
    Grossman, Rachel
    Glas, Martin
    CANCER RESEARCH, 2021, 81 (13)
  • [50] SYMPTOM BURDEN IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA UNDERGOING RADIOTHERAPY PLUS TEMOZOLOMIDE AND ENZASTAURIN: RESULTS FROM A PHASE I/II TRIAL
    Butowski, Nicholas
    Parvataneni, Rupa
    Nicole, Angelina
    Lamborn, Kathleen
    Polley, Mei
    Clarke, Jennifer
    Chang, Susan
    Page, Margaretta
    Prados, Michael
    Liepa, Astra
    Shi, P.
    Thornton, Donald
    NEURO-ONCOLOGY, 2010, 12 : 104 - 104
12345